Header banner
Revain logoHome Page
Cristhian Mcwyersh photo
carupano
4 Level
171 Review
8.25 Karma

Review on Novartis Venture Fund by Cristhian Mcwyersh

Revainrating 4 out of 5

has a long history in medical, technological and scientific financing

this innovative company joins venture capital-based business development through early stage companies, providing large-scale investments depending on how the company takes off, the objective is in technology pharmaceutical, medical, clinical and patented sciences and thus build the development through business growth

beyond the objective of being leaders in this investment industry, it should be noted that this company supports financially, from 30 to 50 million USD, but the amount minimum could start from 100,000 usd, it has a website where you can find all the information in detail





Pros
  • the proposals are potential for the concrete of a negotiation
  • investments are estimated in large amounts over the companies
Cons
  • not